TP53 and breast carcinoma: Owing to the difficulty of upgrading TP53 VUSs and treatment specificity, it might be preferable to consider a Chinese breast cancer patient with a specific TP53 VUS as a TP53 carrier in clinical practice, if the clinical manifestation of the patient conforms to that of a deleterious TP53 mutation.